ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $282,000 | +73.0% | 11,553 | +0.9% | 0.29% | +33.6% |
| Q4 2018 | $163,000 | -6.3% | 11,448 | +0.0% | 0.22% | +35.8% |
| Q3 2018 | $174,000 | -57.1% | 11,447 | -52.7% | 0.16% | -53.4% |
| Q2 2018 | $406,000 | +88.0% | 24,214 | +82.9% | 0.35% | +68.1% |
| Q1 2018 | $216,000 | +21500.0% | 13,236 | +18283.3% | 0.21% | +20600.0% |
| Q4 2017 | $1,000 | 0.0% | 72 | -49.3% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | -95.5% | 142 | -97.1% | 0.00% | -92.3% |
| Q2 2013 | $22,000 | – | 4,837 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |